All Activity

If you are diagnosed with Type-2, then insurance covers the cost. Else you need to pay from your pocket. There are compounded versions too, usually cost around $200/month. Cheapest is Semaglutide but if its pre-diabetic, better to go for Trizeptide. Branded Sema/Tri usually costs upwards of $600-1000 but compounded versions cost around $200-300.

4400 crores…andulo 4000 crores manave…. ayya 260 crs ae tinte koduku ekanga 4000 crs ki panganamam esindu… 4,400 kadu kada okka rupai kuda raadu…lol

Lol pulkas… Pulivendula Medical College is ready for admissions and operations. Miku dhammu vunte, ie college PPP model lo ade Pemmasani, Ponguru, Mothukumilli batch ki private ga appaginchandi…atarvata tamasha chudandi..!!!!

Lol….inthakante pedda comedy inkokati vundadu… Parliament sub-commitee itself is headed by Pemmasani….asalu medical colleges and hospitals provayize chesthe labhapadedi ae pemmasani ae…sub committee kakapothey ministry level la inkemaina sestadu… Oops…Pemmasani ministry kuda health ae…dochukovadaki chala confortable ga vuntadi.

Mee kastalu mamool ga lev ra ayya…. akariki cine 10gina kuda jaggadu ae kavali…

Lol…nuv emana ‘aneka yudhamulu gelichi vachinava’ ? Nuv popular ayindi not because you are a daughter of KCR but because of a tradition and your contribution to highlight the tradition is appreciated. But the mistake you did was that you attempted to own the tradition… With the money amassed, you may live in the limelight for another election but beyond that, you are no one.

Rupee rout dims hopes of a strong recovery in Indian stocks The Indian rupee’s slide to repeated record lows is finally starting to pinch the equity market, with analysts warning that prolonged weakness could undermine confidence in the nascent recovery of the $5.2 trillion stock market. Asia’s worst-performing currency this year is emerging as a near-term threat to a rebound in Indian stocks, despite strong economic growth and a revival in corporate earnings. In December, global funds have withdrawn $1.6 billion from local equities, reversing $1.3 billion of inflows over the prior two months. They have also pulled money from local debt. With India heavily dependent on overseas capital to fund its current-account gap and corporate expansion, sustained outflows threaten to keep equities under pressure. “Foreign investors have continued to pare exposure to Indian equities and debt, resulting in steady dollar outflows,” said Akshat Garg, head of research at Choice Wealth. There is “growing pressure on the currency amid a combination of global uncertainty and India-specific capital flow challenges,” he added. The steepest US tariffs in Asia have weighed on sentiment as traders await the two nations to finalize negotiations. The benchmark NSE Nifty 50 Index retreated about 1.7% from near an all-time high in November, before recovering some losses. The latest setback caps a year in which Indian shares have lagged most emerging-market peers. Slowing earnings growth, elevated valuations and a lack of compelling artificial intelligence-related themes have already driven a rotation toward North Asian markets. The currency has fallen more than 1% in December to 90.7337 per dollar on Monday. Strategists at Kotak Securities expect it to reach 91 by the end of the month. The Reserve Bank of India may not strongly resist further weakness in the current environment, prioritizing growth over currency defense, according to Barclays Plc. That risks prolonging the pain for equities. A weaker rupee does benefit companies that earn a large share of revenue overseas, particularly technology exporters. A gauge of information-technology stocks has climbed about 14% since the end of September, coinciding with the period in which rupee losses deepened. For now, traders are bracing for more volatility as the rupee’s slide compounds concerns over trade, earnings and capital flows. Until the currency stabilizes or global conditions turn more supportive, India’s long-awaited equity rebound may continue to struggle for traction. Equities face muted returns as weaker rupee, range-bound government bond yields, and modest earnings growth “favor selective sectoral exposure,” Dhananjay Sinha, head of research at Systematix Shares and Stocks Ltd. wrote in a note. A sliding rupee benefits tech, pharmaceutical and metal stocks, but hurts banks, energy producers and infrastructure companies, Sinha wrote.

okka daani meeda stand teesukoledu.. safe game.. comedian kabatte intha dooram vachadu.. asalu weekend vaste Nagarjuna mundu amayakapu baaludu laaga aa face petti, eyes bat chesukuntu em moham pedataadoo

We don't have electricity bill for now, excess power generated will go to the grid. In summer, if we consume more than we generate, total units balance chesi emaina migilithe we have to pay for it. But for winter, we don't have any current bill.

That was a sign for you to quit politics ...

If Revant reddy is BAD, I am your DAD ....

The movie was not bad only negative talk killed the movie Ok ok

Abbba tammudu. 10-20% occupancy undi. Janam marchipoyaru. Ee thread ni lepi enduku naa bil ni troll chepisthunnav

Jump to banglore